Comment by mhandley

This article misses the important piece of information that AstraZeneca is producing this vaccine at cost. They're already taking a large financial risk up front by scaling up production in advance for a vaccine that may not pass stage 3 trials, so may not be approved for use. They will make no profit from it, so you cannot really expect them to also accept liability. These are unusual times, and they require unusual approaches.